These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 6317239)

  • 1. Autoantibodies in three populations of Burkitt's lymphoma patients.
    Vainio E; Lenoir GM; Franklin RM
    Clin Exp Immunol; 1983 Nov; 54(2):387-96. PubMed ID: 6317239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The frequency of Epstein-Barr virus infection and Burkitt's lymphoma at high and low altitudes in East Africa.
    Geser A; Brubaker G; Olwit GW
    Rev Epidemiol Sante Publique; 1980 Oct; 28(3):307-21. PubMed ID: 6258200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Smooth muscle antibody in Burkitt's lymphoma and in nasopharyngeal carcinoma.
    Lamelin JP; Williams EH; Souissi T; De-Thé G; Gabbiani G
    Clin Exp Immunol; 1977 Apr; 28(1):157-62. PubMed ID: 193662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epstein-Barr virus-associated Burkitt's lymphoma in India.
    Venkitaraman AR; John TJ; Rangad F; Singh AD; Date A; Lenoir G
    Trop Geogr Med; 1983 Sep; 35(3):273-7. PubMed ID: 6316592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A cluster of Epstein-Barr-virus-associated American Burkitt's lymphoma.
    Judson SC; Henle W; Henle G
    N Engl J Med; 1977 Sep; 297(9):464-8. PubMed ID: 196197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody-dependent cellular cytotoxicity (ADCC) against Epstein-Barr virus-determined antigens. III. Reactivity in sera from patients with Burkitt's lymphoma in relation to tumour development.
    Jondal M; Gunven P
    Clin Exp Immunol; 1977 Jul; 29(1):11-5. PubMed ID: 70292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epstein-Barr virus and Burkitt's lymphoma worldwide: the causal relationship revisited.
    de-Thé G
    IARC Sci Publ; 1985; (60):165-76. PubMed ID: 2998987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Burkitt's lymphoma-Epstein-Barr virus association in western Algeria. Clinical, cytological and serological aspects apropos of 34 pediatric cases].
    Meziane F; Aguercif M; Chevallier A; Lavoue MF; Boukli H; Mehadji M; Boughermouh M
    Pediatrie; 1985 Mar; 40(2):87-98. PubMed ID: 3001633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implications of a vaccine for the prevention of Epstein-Barr virus infection: ethical and logistic considerations.
    Epstein MA
    Cancer Res; 1976 Feb; 36(2 pt 2):711-4. PubMed ID: 175931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Epstein-Barr virus associated Burkitt's lymphoma in a French child (author's transl)].
    Lenoir G; Philip T; Bornkamm GW; Gillet P; Bryon PA; Bouvier R; Dodat H; Doré JF; Brunat-Mentigny M; Hermier M
    Nouv Presse Med; 1979 Dec; 8(49):4031-3. PubMed ID: 93275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strong correlations of anti-viral capsid antigen antibody levels in first-degree relatives from families with Epstein-Barr virus-related lymphomas.
    Besson C; Amiel C; Le-Pendeven C; Plancoulaine S; Bonnardel C; Ranque B; Abbed K; Brice P; Fermé C; Carde P; Hermine O; Raphael M; Bresson JL; Nicolas JC; Gessain A; Dethe G; Abel L
    J Infect Dis; 2009 Apr; 199(8):1121-7. PubMed ID: 19284285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibodies to the R component of Epstein-Barr virus-induced early antigens in Burkitt's lymphoma exceeding in titer antibodies to Epstein-Barr capsid antigen.
    Henle W; Henie G
    J Natl Cancer Inst; 1977 Mar; 58(3):785-6. PubMed ID: 190417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of autoantibodies (ANA, anti ds-DNA, ENA, IMF) and rheumatic syndromes in patients with lymphoproliferative diseases.
    Chloraki-Bobota A; Megalakaki C; Repousis P; Chalkiopoulou I; Lalaki I; Trafalis DT; Athanassiou AE; Mitsouli-Mentzikof C
    J BUON; 2006; 11(4):485-9. PubMed ID: 17309182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune response to different sequences of the EBNA I molecule in Epstein-Barr virus-related disorders and in autoimmune diseases.
    Marchini B; Dolcher MP; Sabbatini A; Klein G; Migliorini P
    J Autoimmun; 1994 Apr; 7(2):179-91. PubMed ID: 7518683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoantibodies (cold lymphocytotoxins, antiactin antibodies and antinuclear factors) in nasopharyngeal carcinoma patients.
    Lamelin JP; de-The G; Revillard JP; Gabbiani G
    IARC Sci Publ (1971); 1978; (20):523-36. PubMed ID: 215532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Restricted low-level human antibody responses against Epstein-Barr virus (EBV)-encoded latent membrane protein 1 in a subgroup of patients with EBV-associated diseases.
    Meij P; Vervoort MB; Aarbiou J; van Dissel P; Brink A; Bloemena E; Meijer CJ; Middeldorp JM
    J Infect Dis; 1999 May; 179(5):1108-15. PubMed ID: 10191211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Burkitt's lymphoma - a human tumor model system for immunological studies.
    Gunvén P
    Biochim Biophys Acta; 1975 Dec; 417(3-4):187-210. PubMed ID: 175835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Epstein-Barr virus and Burkitt's lymphoma].
    Joab I
    Med Trop (Mars); 1999; 59(4 Pt 2):499-502. PubMed ID: 10901854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody levels to infectious agents other than Epstein-Barr virus in Burkitt's lymphoma patients.
    Morrow RH; Sever JL; Henderson BE
    Cancer Res; 1974 May; 34(5):1212-5. PubMed ID: 4366991
    [No Abstract]   [Full Text] [Related]  

  • 20. [Titer of antibodies against Burkitt's lymphoma virus in Burkitt's lymphoma and other diseases].
    Gunven P
    G Batteriol Virol Immunol Ann Osp Maria Vittor Torino; 1972; 65(9):228-32. PubMed ID: 4353758
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.